ASX CEO ASX CEO CONNECT CONNECT 13 October 2020 Alastair Symington Chief Executive Officer
BLACKMORES GROUP Strong commitment to the environment and Founded in 1932 community LEADING natural healthcare company with $568M * 1,000 Unrivalled quality standards IN NET REVENUE; in sourcing and manufacturing quality health * Excludes Global Therapeutics products and services Recognised as one of Australia’s 1,400+ ASX200 best employers STAFF ACROSS ANZ AND COMPANY ASIA; 25% are qualified HCPs 1.2M TOUCHPOINTS educating HCPs, customers, consumers ANNUALLY PRODUCE 4 BILLION capsules and tablets – 33,000 points of distribution
3 Ma 3 Market et Le Lead ading ing Br Bran ands ds #1 market share #1 practitioner brand 6 Natural health Australia 1 , Thailand 2 , & leading VDS cold & flu products for pets Malaysia 3 & Singapore 4 brand with 18% market & highest brand share in Australia 7 awareness in Most trusted brand Australia 8 12 years running 5 1) Nielsen & IQVIA, RMS/Sell Out service, Vitamins and Dietary Supplements, Australia Grocery Pharmacy, Total Retail Sales, Fiscal Year 2020; 2) IQVIA sell out Thailand as of Q1 2020; 3) IQVIA sell in data MAT Q1/2020, Malaysia Pharmacy Channel; 4) Nielsen June 2019; 5) Reader's Digest Most Trusted Brand Survey Australia 2009-2020; 6) IQVIA, MAT to 14 June 2020; 7) Kantar Consumer Brand Health Tracking Study March 2020; 8) Kantar Consumer Brand Health Tracking Study November 2019
Region gional al br bran and d prese pr esence nce South Korea China Taiwan (CN) Hong Kong and Macau (CN) Thailand Vietnam (DISTRIBUTION PARTNERSHIP) Malaysia Kazakhstan (PARTNERSHIP) Singapore Pakistan India Australia Indonesia (JOINT VENTURE) New Zealand Not for distribution, publication or reprint
Our Our Asia Asia foo ootp tprint rint China Innovation 40 + years Centre in Asia #1 Thailand #1 #1 Malaysia 900 8 employees markets Asia wide Singapore, Malaysia, Singapore Thailand, South Korea, Asia regional Indonesia, China, headquarters 600 Hong Kong, Taiwan 3 Indonesia partnerships retail product advisors joint venture with Vietnam, Pakistan, Kazakhstan Kalbe Farma Not for distribution, publication or reprint
WORLD CLASS AUSTRALIAN MADE BRAESIDE CAMPUS World-class manufacturing WARRIEWOOD facility CAMPUS Production BUNGARRIBEE CAMPUS Distribution centre 33,000 points of distribution
Lead Le ading ing na natu tural al he health alth co compa mpany ny #1 Market Highest brand penetration BioCeuticals in market share #1 1 in 4 Practitioner brand Blackmores in in Australia 6 Australia 2 , and leading VDS cold & Thailand 3 , Australian households uses flu brand with 18% Malaysia 4 market share 7 Blackmores products 1 & Singapore 5 Blackmores 82% Blackmores is PAW #1 most #1 brand in by Blackmores trusted Modern highest brand of households Trade - awareness in know Blackmores Indonesia 10 brand (prompted) 8 Australia 11 12 years 20% Top of Mind Awareness running 9 1) Nielsen Homescan 21/4/20; 2) Nielsen & IQVIA, RMS/Sell Out service, Vitamins and Dietary Supplements, Australia Grocery Pharmacy, Total Retail Sales, Fiscal Year 2020; 3) IQVIA sell out Thailand as of Q1 2020; 4) IQVIA sell in data MAT Q1/2020, Malaysia Pharmacy Channel; 5) Nielsen June 2019; 6) IQVIA, MAT to 14 June 2020; 7) IQVIA MAT to 14 June 2020; 8) Kantar Consumer Brand Health Tracking Study March 2020; 9) Reader's Digest Most Trusted Brand Survey 2009-2020; 10) Indonesia Scan Data December 2019; 11) Kantar Consumer Brand Health Tracking Study November 2019
CO COVID VID-19 19 RESP RESPON ONSE SE Health of Health of o our emp ur emplo loyee ees & s & bu busine siness co ss continu ntinuity ity Phase 2 Phase 3 Phase 1 Respond Recover Thrive Launch and sustain a crisis command centre Assess digital capabilities Thought leader: Immunity White Paper Guiding principles for decision making Deeper dive on supply chain agility Identify near-term opportunities and initiate “Micro Battles” and risks • Wellbeing of employees Monitor and adapt to changing consumer Upweight marketing investment on • Government and health department advice behavior and retail dynamics immunity segment • Company values Continued focus on employee wellbeing Upweight digital storytelling • Business continuity to protect – physical and emotional manufacturing Support consumers with access to health advice, search is key Adapt learnings from the China market Cash protection measures in place Workforce flexibility and capability Pressure test strategy under the conditions Importance of communication of “next normal” and how we move to upgrade ongoing Working from home and creating a market shaper rather than simply adapting COVID-19 safe workplace
FY20 FY2 0 Ov Over erview view Full year FY20 underlying NPAT of REVENUE 5 YEARS $18.7m Full year FY20 revenue down 3% on prior year 700 $568m 1 600 Strong growth in International and BioCeuticals offset by softness in Australia and China. 500 $’m 400 Strong improvements in our company-wide Integrated Business Planning processes (IBP) 300 China Innovation Centre established. 200 Strong cash flow of $76m 2 up 46% on prior year 100 FY16 FY17 FY18 FY19 FY20 0 $50m annualised savings by 2023 ANZ BioC 1 China International cost efficiency program to enhance margins substantially by FY23 3 . 1 Excludes Global Therapeutics FY20 as it is a discontinued operation. 2 Operating cash flow before interest and taxes 3 Annualised savings by 2023 compared to the 2020 base year.
FY21 FY21 Towar ards ds Sustaina Sustainable ble Gr Growth wth
OUR GOALS OUR FOCUS 1. Consumers 4. Sustainability To be the most loved, trusted and chosen brand Towards carbon neutral in the categories we play 2. Growth 5. Value BRANDS Consumption ahead of the market, sustained profit Shareholder return performance ahead of the market (EPS) 3. Our People 6. Education Ranked #1 employer of choice in the health #1 Thought leader industry in natural health MARKETS CONSUMER GROWTH China PLATFORMS Core Mental Wellbeing Indonesia Move Modern Parenting Pet Australia
Pr Prog ogres essing sing ou our r st strate tegic gic pr priorities iorities 1 2 3 4 Build a Win with the Rejuvenate Deliver world-class modern career Blackmores new growth organisation woman in China Australia
Design Designing f ing for or Specifically design product the the mode modern n formulations meeting Birth & recovery pa paren ent i t in China n China consumer needs from…. Pre-conception Breastfeeding Blackmores’ premium range of Vitamins and Dietary supplements Aged 0 – 3 Conception specifically designed for modern parenting. China as lead market Aged 4 – 7 Pregnancy from September 2020. Restore Blackmores’ position in Modern Parenting by helping women across their pregnancy and parenting journey.
Out Outlook look Due to current global uncertainty no full year profit outlook for FY21, however, we anticipate full year profit growth in FY21 despite additional cost variances arising from Braeside manufacturing ownership. Profit growth will come predominantly from the second half of the fiscal year. Confidence in our renewed strategy to put the company back on the path to sustainable, profitable growth and restore future dividends.
Thank hank you. ou.
Recommend
More recommend
